Growth Metrics

Novavax (NVAX) Notes Payables (2016 - 2022)

Novavax (NVAX) has 8 years of Notes Payables data on record, last reported at $324.9 million in Q4 2022.

  • For Q4 2022, Notes Payables changed N/A year-over-year to $324.9 million; the TTM value through Dec 2022 reached $324.9 million, changed N/A, while the annual FY2022 figure was $324.9 million, N/A changed from the prior year.
  • Notes Payables reached $324.9 million in Q4 2022 per NVAX's latest filing, roughly flat from $324.5 million in the prior quarter.
  • Across five years, Notes Payables topped out at $324.9 million in Q4 2022 and bottomed at $323.8 million in Q1 2022.